
Titilayo Moloye
Examiner (ID: 7696)
| Most Active Art Unit | 1632 |
| Art Unit(s) | 1632 |
| Total Applications | 637 |
| Issued Applications | 335 |
| Pending Applications | 112 |
| Abandoned Applications | 220 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18257161
[patent_doc_number] => 20230084201
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => SYSTEMS AND METHODS FOR IN VIVO DUAL RECOMBINASE-MEDIATED CASSETTE EXCHANGE (dRMCE) AND DISEASE MODELS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/930558
[patent_app_country] => US
[patent_app_date] => 2022-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12484
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17930558
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/930558 | SYSTEMS AND METHODS FOR IN VIVO DUAL RECOMBINASE-MEDIATED CASSETTE EXCHANGE (dRMCE) AND DISEASE MODELS THEREOF | Sep 7, 2022 | Pending |
Array
(
[id] => 18093483
[patent_doc_number] => 20220411824
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-29
[patent_title] => COMPOSITIONS AND METHODS FOR INCREASING THE EFFICIENCY OF CELL CULTURES USED FOR FOOD PRODUCTION
[patent_app_type] => utility
[patent_app_number] => 17/929652
[patent_app_country] => US
[patent_app_date] => 2022-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23249
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17929652
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/929652 | COMPOSITIONS AND METHODS FOR INCREASING THE EFFICIENCY OF CELL CULTURES USED FOR FOOD PRODUCTION | Sep 1, 2022 | Pending |
Array
(
[id] => 18165211
[patent_doc_number] => 20230031809
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-02
[patent_title] => TREATMENT OF DISEASES INVOLVING DEFICIENCY OF ENPP1 OR ENPP3
[patent_app_type] => utility
[patent_app_number] => 17/822245
[patent_app_country] => US
[patent_app_date] => 2022-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42722
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17822245
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/822245 | TREATMENT OF DISEASES INVOLVING DEFICIENCY OF ENPP1 OR ENPP3 | Aug 24, 2022 | Pending |
Array
(
[id] => 18159655
[patent_doc_number] => 20230026247
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => METHOD OF MAKING A PERSONALIZED BONE GRAFT
[patent_app_type] => utility
[patent_app_number] => 17/890322
[patent_app_country] => US
[patent_app_date] => 2022-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6092
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17890322
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/890322 | METHOD OF MAKING A PERSONALIZED BONE GRAFT | Aug 17, 2022 | Abandoned |
Array
(
[id] => 18595998
[patent_doc_number] => 20230270789
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => COMBINATORIAL CANCER IMMUNOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 17/872827
[patent_app_country] => US
[patent_app_date] => 2022-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26455
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17872827
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/872827 | COMBINATORIAL CANCER IMMUNOTHERAPY | Jul 24, 2022 | Abandoned |
Array
(
[id] => 20646031
[patent_doc_number] => 12600968
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-04-14
[patent_title] => Methods and compositions for reprogramming cells
[patent_app_type] => utility
[patent_app_number] => 17/869514
[patent_app_country] => US
[patent_app_date] => 2022-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 23
[patent_no_of_words] => 12708
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17869514
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/869514 | Methods and compositions for reprogramming cells | Jul 19, 2022 | Issued |
Array
(
[id] => 19258228
[patent_doc_number] => 12018274
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-25
[patent_title] => Compositions and methods for regulating production of a fusion protein and ribonucleic acid
[patent_app_type] => utility
[patent_app_number] => 17/867881
[patent_app_country] => US
[patent_app_date] => 2022-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 6613
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17867881
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/867881 | Compositions and methods for regulating production of a fusion protein and ribonucleic acid | Jul 18, 2022 | Issued |
Array
(
[id] => 18075906
[patent_doc_number] => 20220401518
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => MESENCHYMAL STEM CELL EXPRESSING HEPATOCYTE GROWTH FACTOR, AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/853208
[patent_app_country] => US
[patent_app_date] => 2022-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5041
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17853208
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/853208 | MESENCHYMAL STEM CELL EXPRESSING HEPATOCYTE GROWTH FACTOR, AND USE THEREOF | Jun 28, 2022 | Pending |
Array
(
[id] => 18075879
[patent_doc_number] => 20220401491
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => MESENCHYMAL STEM CELL EXPRESSING TRAIL AND CD, AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/853259
[patent_app_country] => US
[patent_app_date] => 2022-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6358
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17853259
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/853259 | MESENCHYMAL STEM CELL EXPRESSING TRAIL AND CD, AND USE THEREOF | Jun 28, 2022 | Abandoned |
Array
(
[id] => 18034627
[patent_doc_number] => 20220378842
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => COMBINATORIAL CANCER IMMUNOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 17/848320
[patent_app_country] => US
[patent_app_date] => 2022-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61809
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17848320
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/848320 | COMBINATORIAL CANCER IMMUNOTHERAPY | Jun 22, 2022 | Pending |
Array
(
[id] => 17990228
[patent_doc_number] => 20220356265
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-10
[patent_title] => ANTI-GLYPICAN-1-IMMUNIZING ANTIGEN RECEPTOR
[patent_app_type] => utility
[patent_app_number] => 17/846446
[patent_app_country] => US
[patent_app_date] => 2022-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7430
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17846446
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/846446 | ANTI-GLYPICAN-1-IMMUNIZING ANTIGEN RECEPTOR | Jun 21, 2022 | Pending |
Array
(
[id] => 18005283
[patent_doc_number] => 20220364049
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-17
[patent_title] => COMPOSITION AND METHODS FOR CULTURING RETINAL PROGENITOR CELLS
[patent_app_type] => utility
[patent_app_number] => 17/845461
[patent_app_country] => US
[patent_app_date] => 2022-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20557
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17845461
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/845461 | COMPOSITION AND METHODS FOR CULTURING RETINAL PROGENITOR CELLS | Jun 20, 2022 | Pending |
Array
(
[id] => 20329898
[patent_doc_number] => 12460165
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-04
[patent_title] => Growth media for three-dimensional cell culture
[patent_app_type] => utility
[patent_app_number] => 17/841917
[patent_app_country] => US
[patent_app_date] => 2022-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 10
[patent_no_of_words] => 3674
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17841917
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/841917 | Growth media for three-dimensional cell culture | Jun 15, 2022 | Issued |
Array
(
[id] => 17895399
[patent_doc_number] => 20220305061
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => COMPOSITIONS DERIVED FROM HUMAN AMNION CELLS & RELATED METHODS
[patent_app_type] => utility
[patent_app_number] => 17/842156
[patent_app_country] => US
[patent_app_date] => 2022-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6300
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 227
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17842156
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/842156 | COMPOSITIONS DERIVED FROM HUMAN AMNION CELLS & RELATED METHODS | Jun 15, 2022 | Abandoned |
Array
(
[id] => 18272486
[patent_doc_number] => 20230093728
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => CELL IMMORTALIZATION VIA VORTEX ELECTROPORATION GENE DELIVERY
[patent_app_type] => utility
[patent_app_number] => 17/735802
[patent_app_country] => US
[patent_app_date] => 2022-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8733
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17735802
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/735802 | CELL IMMORTALIZATION VIA VORTEX ELECTROPORATION GENE DELIVERY | May 2, 2022 | Abandoned |
Array
(
[id] => 17911348
[patent_doc_number] => 20220313743
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => COMPOSITIONS CONTAINING AMNIOTIC COMPONENTS AND METHODS FOR PREPARATION AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/731176
[patent_app_country] => US
[patent_app_date] => 2022-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34632
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17731176
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/731176 | COMPOSITIONS CONTAINING AMNIOTIC COMPONENTS AND METHODS FOR PREPARATION AND USE THEREOF | Apr 26, 2022 | Pending |
Array
(
[id] => 18018166
[patent_doc_number] => 20220369665
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => Generation of Cell-Based Products for Human Consumption
[patent_app_type] => utility
[patent_app_number] => 17/661014
[patent_app_country] => US
[patent_app_date] => 2022-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15089
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17661014
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/661014 | Generation of Cell-Based Products for Human Consumption | Apr 26, 2022 | Pending |
Array
(
[id] => 17789636
[patent_doc_number] => 20220248727
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => METHODS FOR PREPARING A COMESTIBLE MEAT PRODUCT
[patent_app_type] => utility
[patent_app_number] => 17/660165
[patent_app_country] => US
[patent_app_date] => 2022-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17659
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17660165
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/660165 | Methods for preparing a comestible meat product | Apr 20, 2022 | Issued |
Array
(
[id] => 17789637
[patent_doc_number] => 20220248728
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => SUBSTRATES FOR PREPARING A COMESTIBLE MEAT PRODUCT
[patent_app_type] => utility
[patent_app_number] => 17/660170
[patent_app_country] => US
[patent_app_date] => 2022-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17667
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17660170
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/660170 | Substrates for preparing a comestible meat product | Apr 20, 2022 | Issued |
Array
(
[id] => 17775113
[patent_doc_number] => 20220241462
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => BIOPROSTHETIC TISSUE HAVING A REDUCED PROPENSITY FOR IN VIVO CALCIFICATION
[patent_app_type] => utility
[patent_app_number] => 17/659589
[patent_app_country] => US
[patent_app_date] => 2022-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6770
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17659589
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/659589 | BIOPROSTHETIC TISSUE HAVING A REDUCED PROPENSITY FOR IN VIVO CALCIFICATION | Apr 17, 2022 | Abandoned |